News tagged with american society of clinical oncology
Related topics: cancer , cancer patients , chemotherapy
Intermountain Healthcare Cancer research provides possible road map for improving healthcare
Given the right equipment, training and skill, an individual surgeon can expect to provide the best possible care on a consistent basis. But how do you get an entire system of surgeons—each with his or her own ideas, backgrounds, ...
Health
Nov 30, 2012 |
not rated yet |
0
Most women who have double mastectomy don't need it, study finds
About 70 percent of women who have both breasts removed following a breast cancer diagnosis do so despite a very low risk of facing cancer in the healthy breast, new research from the University of Michigan Comprehensive ...
Cancer
Nov 27, 2012 |
not rated yet |
0
Phase III worldwide study of new drug for patients with pancreatic cancer
A new cancer drug combination demonstrated significant improvement in overall survival of late-stage pancreatic cancer patients compared to those receiving standard treatment, according to results of a Phase III clinical ...
Cancer
Nov 19, 2012 |
not rated yet |
0
Prostate cancer diagnosis and surgery can lead to anxiety, depression and reduced quality of life
Men who undergo surgical removal of prostate cancer can experience significant levels of anxiety one year after surgery, and higher levels of anxiety appear to be linked to poor sexual satisfaction and depression, say researchers ...
Cancer
Sep 24, 2012 |
not rated yet |
0
New device may reduce repeat breast cancer surgeries
(HealthDay)—A new device meant to help surgeons determine in the operating room if they have removed all cancerous breast cancer tissue may help reduce repeat surgeries after lumpectomy without compromising ...
Cancer
Sep 12, 2012 |
not rated yet |
0
Some screens miss spread of breast cancer: study
(HealthDay)—In a new study, three types of screening methods used to determine whether breast cancer has spread to other parts of the body only spotted a small portion of tumors that had done so.
Cancer
Sep 12, 2012 |
not rated yet |
0
Crizotinib reduces tumor size in patients with ALK positive lung cancer
Crizotinib is effective in shrinking tumors in patients with anaplastic lymphoma receptor tyrosine kinase (ALK) positive non-small cell lung cancer, a cancer commonly found in people who never smoked, and should be the standard ...
Cancer
Sep 06, 2012 |
not rated yet |
0
Marital status, race increase survival rate significantly for Stage III non-small cell lung cancer patients
A study of survival data for Stage III, non-small cell lung cancer (NSCLC) patients at the University of Maryland's Greenebaum Cancer Center in Baltimore indicates that marital status and race can significantly impact patient ...
Cancer
Sep 06, 2012 |
not rated yet |
0
Standard chemotherapy provides higher survival rate than experimental in lung cancer patients
Treatment with pemetrexed, carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab (Pem+Cb+B) is no better than standard therapy with paclitaxel, carboplatin and bevacizumab followed by bevacizumab ...
Cancer
Sep 06, 2012 |
not rated yet |
0
Hispanic lung cancer patients have higher survival than non-Hispanic white patients
Analysis of non-small cell lung cancer (NSCLC) patient records in the California Cancer Registry (CCR) database during the 20-year period of 1988-2008 indicates that Hispanics/Latinos with NSCLC have a higher overall survival ...
Cancer
Sep 06, 2012 |
not rated yet |
0
Brain radiation after lung cancer treatment reduces risk of cancer spreading
Stage III non-small cell lung cancer (NSCLC) patients treated with surgery and/or radiation therapy have a significantly reduced risk of developing brain metastases if they also receive prophylactic cranial irradiation (PCI); ...
Cancer
Sep 06, 2012 |
not rated yet |
0
Adding bavituximab to second-line chemotherapy doubles response rate
Adding the monoclonal antibody bavituximab to docetaxel chemotherapy doubles overall response rate and improves progression-free survival and overall survival in late-stage non-squamous, non-small cell lung cancer (NS-NSCLC) ...
Cancer
Sep 06, 2012 |
5 / 5 (2) |
0
Stage I NSCLC patients who receive radiation therapy are surviving longer
Stage I, non-small cell lung cancer (NSCLC) patients who received radiation therapy have an increased median survival of 21 months compared to 16 months, and the percentage of patients who receive no treatment declined from ...
Cancer
Sep 06, 2012 |
not rated yet |
0
HPV test beats pap long-term: study
(HealthDay) -- Testing for HPV, the human papillomavirus linked to cervical cancer, can predict which women will stay cancer-free for a decade or more, a new study shows.
Cancer
Jul 30, 2012 |
not rated yet |
0
|
Benefits of prostate-specific antigen testing remain unclear
(HealthDay) -- It remains unclear whether the benefits of prostate-specific antigen (PSA) testing outweigh the harms, but evidence suggests that men with a longer life expectancy may benefit from testing, ...
Cancer
Jul 20, 2012 |
not rated yet |
3
|
